As with BD, treatment of iBD is initiated with 5-aminosalicylic acid, corticosteroids, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody therapy [5]. This evidence concerns the gene TNF and inflammatory bowel disease.